Navigation Links
Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis

Schlieren (Zurich), Switzerland, May 24, 2007 - Cytos Biotechnology AG (SWX:CYTN) reported today results from a placebo-controlled, double-blind combined phase I/IIa study with CYT007-TNFQb, a novel vaccine candidate for the treatment of psoriasis and other inflammatory conditions. The present study was a first-time-in-man clinical trial and included 48 patients suffering from moderate to severe plaque psoriasis. In a first part of the study, the safety and tolerability of ascending doses of CYT007-TNFQb were assessed in 24 patients. In the following second part of the study, the exploratory efficacy of the highest vaccine dose was compared to placebo in another 24 patients.

All doses of CYT007-TNFQb tested were safe and well tolerated. All the patients who received the vaccine mounted an antibody response against TNF-?. Exploratory efficacy was assessed according to the Psoriasis Area and Severity Index (PASI), a commonly used measure to evaluate the disease severity in psoriatic patients. The graph below shows the course of the PASI scores throughout the study period (i.e. from baseline up to week 16) for the CYT007-TNFQb-treated and the placebo group.


SEE ATTACHMENT FOR CHART

Dr. Wolfgang Renner, CEO of Cytos Biotechnology, commented the study results: “The prime objective of this first-time-in-man clinical trial was to demonstrate safety and tolerability of this novel vaccine candidate. This objective was clearly reached. With regard to efficacy we are seeing a temporary improvement of the disease. We will now in detail analyse a broad set of biochemical markers in order to determine whether this observed improvement of disease is indeed treatment related. This additional analytical and laboratory work, which will take several months to complete, will then guide us in the further development of this novel vaccine candidate.”

Cytos Biotechnology will discuss the development program for CYT007-TNFQb
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:11/26/2014)... DALLAS , November 25, 2014 ... Surgical Instruments Market by Power Source (Electric, Battery, ... Console, Cables, Blade, Burr, Cart), by Application (Orthopedic, ... 2019" published by MarketsandMarkets, the global Powered Surgical Instruments ... to $1.6 Billion in 2014 and is expected ...
(Date:11/26/2014)... SAN FRANCISCO , Nov. 25, 2014  goBalto, ... solutions, has been recognized as a winner of Red ... received a Global Top 100 North America award in ... the international technology landscape. Red Herring,s Top ... for identifying promising new companies and entrepreneurs. Red Herring ...
(Date:11/26/2014)... Nov. 25, 2014  Medtronic,s roughly $43 ... been widely discussed in the media for its ... a stronger leading player in one of the ... The healthcare market research firm said  the two ... a diverse set of solutions spanning inpatient to ...
Breaking Medicine Technology:Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3
... Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of ... neuro-otologic, vestibular and neurological testing, said today that ... control and analysis software. Clinical specialists ... conduct vestibular, oculomotor and optokinetic tests to detect ...
... of Wolters Kluwer Health and ... for the medical, scientific, and academic markets, is pleased to announce ... the first clinical tool from Ovid designed especially for physicians ... on relevant full-text content from Ovid. It,s the only solution that ...
Cached Medicine Technology:Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software 2Ovid Announces its First Clinical Tool, OvidMD, Designed for Physicians and Other Clinicians 2Ovid Announces its First Clinical Tool, OvidMD, Designed for Physicians and Other Clinicians 3Ovid Announces its First Clinical Tool, OvidMD, Designed for Physicians and Other Clinicians 4
(Date:11/28/2014)... Agein.com, the Internet’s premier anti-aging web site ... the foremost experts in the industry, is releasing its top ... winter. , “The official start of winter is still three ... hit with an icy blast. After one of the worst ... will usher in another brutal winter,” says Dr. Kevin J. ...
(Date:11/28/2014)... York, NY (PRWEB) November 28, 2014 ... Salvage ( http://www.rustysautosalvage.com ), one of the nation's leading ... junk and salvage vehicles to be more competitive and ... customer’s lives during this festive time of year. , ... many car owners across the US also deal with ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 On Monday, ... and Sendik’s will present Feeding America Eastern Wisconsin with ... Food Market to donate a portion of proceeds to ... Sendik’s promotion, “7 Days, 7 Ways to Save” with ... Fyffes pineapples were two for $4 and Turbana bananas ...
(Date:11/28/2014)... Miami, FL (PRWEB) November 28, 2014 ... contemporary, responsive website. Practice founder Dr. Jeffrey ... site. Created using a groundbreaking WordPress platform, the ... devices. , Currently, up to 75% of ... More than ever, these people are logging on with ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Written and narrated ... Brook Forest Voices releases the “The Happiest Man In ... a compelling account of how and why Project C.U.R.E. came ... by his mother Josie and the Reverend Richard W. Jackson, ... the age of 30, but realized that he wasn’t happy. ...
Breaking Medicine News(10 mins):Health News:Agein Corporation, a Leading Anti-Aging Company, Releases Top Diet and Personal Care Tips for Preventing Dry Skin this Season 2Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 3Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2
... LINDA, Calif., Nov. 5 For any woman ... woman trapped in an abusive relationship,without the confidence ... Spanish-language novel, "Yo Mujer" (published by AuthorHouse --, ... the inspirational story of one woman,s journey to,freedom ...
... and Redwood Shores, CA November 4, 2008 ... Navigenics, Inc. today announced a medical education program ... factors for disease, the current evidence about the ... risk, and promising practices for utilizing those tools ...
... Through the ... ... York Times best-selling author Ellie Krieger, of Food Network,fame, joins Yoplait(R) ... contains live and active probiotic cultures,specifically designed for digestive health and ...
... earnings projection --, LAKE FOREST, Ill., Nov. 5 Hospira, ... company, today reported results for the third quarter of 2008., ... the third quarter of 2008, compared to ... 2007. -- Adjusted* diluted earnings per share increased 28.6 percent ...
... BRANFORD, Conn., Nov. 5 CuraGen Corporation,(Nasdaq: CRGN ... that Dr. Timothy M. Shannon, President and Chief,Executive Officer, ... Renshaw,Annual Global Investment Conference on Wednesday, November 12, 2008, ... at the New York Palace,Hotel in New York, NY., ...
... Californians for SAFE Food, the,statewide coalition endorsing ... to the California family farmers, food safety and ... community,groups who lent their energy, expertise and support ... Yes on 2 campaign, backed by one of ...
Cached Medicine News:Health News:'Yo Mujer': Woman Escapes from Abusive Marriage in New Spanish-Language Novel 2Health News:New program to help physicians understand role of DNA-based preventive medicine 2Health News:Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health 2Health News:Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health 3Health News:Hospira Reports Third-Quarter 2008 Results 2Health News:Hospira Reports Third-Quarter 2008 Results 3Health News:Hospira Reports Third-Quarter 2008 Results 4Health News:Hospira Reports Third-Quarter 2008 Results 5Health News:Hospira Reports Third-Quarter 2008 Results 6Health News:Hospira Reports Third-Quarter 2008 Results 7Health News:Hospira Reports Third-Quarter 2008 Results 8Health News:Hospira Reports Third-Quarter 2008 Results 9Health News:Hospira Reports Third-Quarter 2008 Results 10Health News:Hospira Reports Third-Quarter 2008 Results 11Health News:Hospira Reports Third-Quarter 2008 Results 12Health News:Hospira Reports Third-Quarter 2008 Results 13Health News:Hospira Reports Third-Quarter 2008 Results 14Health News:Hospira Reports Third-Quarter 2008 Results 15Health News:Hospira Reports Third-Quarter 2008 Results 16Health News:Hospira Reports Third-Quarter 2008 Results 17Health News:Hospira Reports Third-Quarter 2008 Results 18Health News:Hospira Reports Third-Quarter 2008 Results 19Health News:Hospira Reports Third-Quarter 2008 Results 20Health News:Hospira Reports Third-Quarter 2008 Results 21Health News:Hospira Reports Third-Quarter 2008 Results 22Health News:Hospira Reports Third-Quarter 2008 Results 23Health News:Hospira Reports Third-Quarter 2008 Results 24Health News:Hospira Reports Third-Quarter 2008 Results 25Health News:Hospira Reports Third-Quarter 2008 Results 26Health News:Hospira Reports Third-Quarter 2008 Results 27Health News:Hospira Reports Third-Quarter 2008 Results 28
Bivona® Uncuffed Neonatal and Pediatric Silicone Tracheostomy Tubes....
Fome-Cuf® tubes can breathe with the patient to provide a safe, effective, and low pressure seal throughout the ventilatory cycle....
... flange tracheostomy tubes are intended ... proper length fixed neck flange ... ,Adjustable neck flange Hyperflex™ ... for both horizontal and vertical ...
... Neonatal and Pediatric TRACH ... a multi access catheter ... lavage/irrigation port and locking ... sizes and packaging configurations. ...
Medicine Products: